Cervical Chronicles: Navigating the Evolving Landscape of Treatment is organized by Healio, Integrity Continuing Education Inc.
Release Date: November 8, 2023
Expiration Date: November 8, 2024
Description:
The incidence of cervical cancer may be decreasing due to widespread screening and prevention efforts and improved access to care, but racial and ethnic disparities remain in both cervical cancer incidence and mortality, with higher rates among Black and Hispanic women than White women. Further, there is an obvious need for treatment options that provide durable and meaningful improvements in survival – approximately half of the women (48%) who complete first-line (1L) therapy for cervical cancer in community-based care subsequently receive second-line therapy, with a median treatment-free interval of only 2.1 months. However, the treatment landscape is changing, and recent data has shown a survival benefit with the addition of immune checkpoint inhibitors to 1L chemotherapy, which may improve the outlook for many women with cervical cancer.
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
• Apply recommendations and clinical trial evidence to treatment and adverse event management for women with cervical cancer
• Identify the effects of and strategies to overcome disparities in care